Identificador persistente para citar o vincular este elemento: https://accedacris.ulpgc.es/jspui/handle/10553/156306
Campo DC Valoridioma
dc.contributor.authorVolz, Eriken_US
dc.contributor.authorMishra, Swapnilen_US
dc.contributor.authorChand, Meeraen_US
dc.contributor.authorBarrett, Jeffrey C.en_US
dc.contributor.authorJohnson, Roberten_US
dc.contributor.authorGeidelberg, Lilyen_US
dc.contributor.authorHinsley, Wes R.en_US
dc.contributor.authorLaydon, Daniel J.en_US
dc.contributor.authorDabrera, Gavinen_US
dc.contributor.authorO’Toole, Áineen_US
dc.contributor.authorAmato, Roberten_US
dc.contributor.authorRagonnet-Cronin, Manonen_US
dc.contributor.authorHarrison, Ianen_US
dc.contributor.authorJackson, Benen_US
dc.contributor.authorAriani, Cristina V.en_US
dc.contributor.authorBoyd, Oliviaen_US
dc.contributor.authorLoman, Nicholas J.en_US
dc.contributor.authorMcCrone, John T.en_US
dc.contributor.authorGonçalves, Sóniaen_US
dc.contributor.authorJorgensen, Daviden_US
dc.contributor.authorMyers, Richarden_US
dc.contributor.authorHill, Verityen_US
dc.contributor.authorJackson, David K.en_US
dc.contributor.authorGaythorpe, Katyen_US
dc.contributor.authorGroves, Natalieen_US
dc.contributor.authorSillitoe, Johnen_US
dc.contributor.authorKwiatkowski, Dominic P.en_US
dc.contributor.authorFlaxman, Sethen_US
dc.contributor.authorRatmann, Oliveren_US
dc.contributor.authorBhatt, Samiren_US
dc.contributor.authorHopkins, Susanen_US
dc.contributor.authorGandy, Axelen_US
dc.contributor.authorRambaut, Andrewen_US
dc.contributor.authorFerguson, Neil M.en_US
dc.contributor.authorBetancor Quintana, Gilberto Joseen_US
dc.date.accessioned2026-01-28T15:14:12Z-
dc.date.available2026-01-28T15:14:12Z-
dc.date.issued2021en_US
dc.identifier.issn0028-0836en_US
dc.identifier.urihttps://accedacris.ulpgc.es/jspui/handle/10553/156306-
dc.description.abstractThe SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public Health England1, was first identified in the UK in late summer to early autumn 20202. Whole-genome SARS-CoV-2 sequence data collected from community-based diagnostic testing for COVID-19 show an extremely rapid expansion of the B.1.1.7 lineage during autumn 2020, suggesting that it has a selective advantage. Here we show that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S gene target failures (SGTF) in community-based diagnostic PCR testing. Analysis of trends in SGTF and non-SGTF case numbers in local areas across England shows that B.1.1.7 has higher transmissibility than non-VOC lineages, even if it has a different latent period or generation time. The SGTF data indicate a transient shift in the age composition of reported cases, with cases of B.1.1.7 including a larger share of under 20-year-olds than non-VOC cases. We estimated time-varying reproduction numbers for B.1.1.7 and co-circulating lineages using SGTF and genomic data. The best-supported models did not indicate a substantial difference in VOC transmissibility among different age groups, but all analyses agreed that B.1.1.7 has a substantial transmission advantage over other lineages, with a 50% to 100% higher reproduction number.en_US
dc.languageengen_US
dc.relation.ispartofNatureen_US
dc.sourceNature (eISSN 0028-0836), v. 593, pp. 266-269 (Marzo 2021)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320505 Enfermedades infecciosasen_US
dc.subject320102 Genética clínicaen_US
dc.subject.otherPopulation geneticsen_US
dc.subject.otherSARS-CoV-2en_US
dc.subject.otherViral infectionen_US
dc.titleAssessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in Englanden_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1038/s41586-021-03470-xen_US
dc.description.lastpage269en_US
dc.identifier.issue7858-
dc.description.firstpage266en_US
dc.relation.volume593en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.notas*Miembro de COVID-19 Genomics UK (COG-UK) consortiumen_US
dc.description.numberofpages4en_US
dc.utils.revisionen_US
dc.date.coverdateMarzo 2021en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr17,897
dc.description.jcr69,504
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
dc.description.miaricds11,0
dc.description.erihplusERIH PLUS
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Trypanosomosis, Resistencia a Antibióticos, Virología y Medicina Animal-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0003-0548-7690-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameBetancor Quintana, Gilberto Jose-
Colección:Artículos
Vista resumida

Citas de WEB OF SCIENCETM
Citations

818
actualizado el 22-feb-2026

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.